Act 1 adaptor protein

Last updated June 26, 2024

Act 1 adaptor protein (Act 1) is an essential intermediate in the interleukin-17 pathway. The IL-17 protein is a pro-inflammatory cytokine important for tissue inflammation in host defense against infection and in autoimmune disease. It is produced by the CD4 + T cells, in particular the Th17 cells. There are 6 subtypes of IL-17, from IL-17A to IL17-F, these subtypes have nearly identical structures. We know that the cytokines are interacting homotypically, but IL-17A and IL-17F are capable do perform heterotypic interaction too.^[1]

Each cytokine has its own receptor, IL-17RA to IL-17F, and their pathways are still under investigation. It has been proven that these receptors are not using MyD88 and IRAK in their signaling pathways. They indeed use the adaptor Act1 protein, and TRAF family protein in order to activate the nuclear factor-kappa B (NF-κB),^[2] a transcription factor involved in the immunity response (see the pathways explanation below).^[3] This protein has different binding sites, which can physically attach the different components in order to activate them.

Act1 is crucial in the IL-17 signaling pathway. Moreover, this protein is only used in cells expressing CD40 and CD40L, which are also from the tumor necrosis receptor superfamily and more importantly expressed by B cells. It can also be expressed by other cell types such as epithelial cells, monocytes, basophils, dendritic cells, fibroblasts, smooth muscle cells, endothelial cells. Therefore, Act1 has a very wide impact on the immune system.

Act1 malfunction could induce autoimmunity (see below).

Structure

Some studies have been done in order to understand the structure of each subunit, and their importance in the protein function:^[4]

C-Terminal SEFIR domain (residues 394 to 574): This domain is shared by the Act1 protein and the IL-17R. It has been shown that the two components interact through this domain physically. It allows to start the IL-17 pathway by direct contact between the receptor and the adaptor.
U3-box: Site in which Act1 can perform the ubiquitination of other proteins.
TRAF domains (residues 35 to 42, and 333 to 337): Act1 has two TRAF domains. Act1 will interact with the TRAF family proteins, in particular, TRAF6 in order to activate the NF-κB pathway. Indeed, Act1 polyubiquitinates TRAF6. TRAF6 will then be activated and recruit TAK1 (TGFβ Activated Kinase 1 ), leading to the activation of NF-κB.
HLH-domain (residues 135 to 190): It is a helix-loop-helix (HLH) which allow the interaction with the IkB kinase protein (IKK). This protein allows the phosphorylation of IkB, which is part of a trimer of protein and sequestering the NF-κB. When IKK interacts with Act1, this one will be activated, phosphorylate IkB inducing the releasing of NF-κB which translocates into the nucleus and induces gene expression.

Act1 in the IL-17 pathway

When IL-17 binds to its receptor, IL-17R is activated and recruits Act1 adaptor through the SEFIR domain that they are both sharing.

NF-κB is kept inactive in the cytoplasm by the IkB subunits which is part of a complex composed of two other subunits: IKKγ and IKKα.

Subsequently, Act1 recruits TRAF6 through its TRAF domain and ubiquitinates this protein. Once this protein is ubiquitinated, it will recruit TAK1. It leads to the polyubiquitination of IkB which releases NF-κB, allowing its translocation inside the nucleus.

Act1 also recruits the IKK complex through its HLH domain. This complex phosphorylates the IkB protein which will release as well NF-κB and induce its activation.

Act1 used by CD40 receptor

Act1 activates NF-κB through the TAK1 and IKK proteins. Nevertheless, TRAF3 is also involved when the CD40 receptor is activated.^[6] When CD40 is stimulated by CD40L, Act1 binds to TRAF3, with the help of TRAF2 and 5 in order to activate the JNK proteins. The precise function of TRAF3 remains unknown. Indeed, depending on the TRAF variants involved, the protein has an activatory or inhibitory signal for NF-κB activation. It has been shown that there is mostly an inhibition in the NF-κB signaling when TRAF3 is activated. But, due to the splicing, some variants of TRAF3 have been identified to activate the NF-κB pathway, as well as the TRAF2 and 5. Furthermore, the activation of NF-κB induces the inhibition of the CD40L-induced apoptosis. The function of TRAF3 is complex and not yet fully understood.

Act1 adaptor and diseases

Act1 is an important protein for the immune system functions.^[1] Furthermore, its dysfunction is involved in autoimmunity or other diseases, such as allergic airway inflammation^[1] or psoriatic arthritis.^[4] When the Th17 cell number is enhanced, it leads to the over-production of IL-17, inducing Act1 activation and inflammation, and autoimmunity.

Given the fact that Act1 inhibits the CD40-40L stimulation, its loss would induce an accumulation of B cell population. This enhancement of cells number triggers lymphoma and antibody production, leading to auto-immunity.

Some studies have shown that Act1 could be involved in psoriatic arthritis due to SNP (single nucleotide polymorphism), but the mechanism in which it takes place is still under investigation.

Study this adaptor could be a way to treat the disease related to the IL-17 signaling and Th17 cells.

Related Research Articles

Cluster of differentiation 40, CD40 is a type I transmembrane protein found on antigen-presenting cells and is required for their activation. The binding of CD154 (CD40L) on T_H cells to CD40 activates antigen presenting cells and induces a variety of downstream effects.

Receptor activator of nuclear factor κ B (RANK), also known as TRANCE receptor or TNFRSF11A, is a member of the tumor necrosis factor receptor (TNFR) molecular sub-family. RANK is the receptor for RANK-Ligand (RANKL) and part of the RANK/RANKL/OPG signaling pathway that regulates osteoclast differentiation and activation. It is associated with bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development. Osteoprotegerin (OPG) is a decoy receptor for RANKL, and regulates the stimulation of the RANK signaling pathway by competing for RANKL. The cytoplasmic domain of RANK binds TRAFs 1, 2, 3, 5, and 6 which transmit signals to downstream targets such as NF-κB and JNK.

NF-kappa-B essential modulator (NEMO) also known as inhibitor of nuclear factor kappa-B kinase subunit gamma (IKK-γ) is a protein that in humans is encoded by the IKBKG gene. NEMO is a subunit of the IκB kinase complex that activates NF-κB. The human gene for IKBKG is located on the chromosome band Xq28. Multiple transcript variants encoding different isoforms have been found for this gene.

TIR domain containing adaptor molecule 1 is an adapter in responding to activation of toll-like receptors (TLRs). It mediates the rather delayed cascade of two TLR-associated signaling cascades, where the other one is dependent upon a MyD88 adapter.

TRAF6 is a TRAF human protein.

TNF receptor-associated factor 2 is a protein that in humans is encoded by the TRAF2 gene.

IKK-β also known as inhibitor of nuclear factor kappa-B kinase subunit beta is a protein that in humans is encoded by the IKBKB gene.

Inhibitor of nuclear factor kappa-B kinase subunit alpha (IKK-α) also known as IKK1 or conserved helix-loop-helix ubiquitous kinase (CHUK) is a protein kinase that in humans is encoded by the CHUK gene. IKK-α is part of the IκB kinase complex that plays an important role in regulating the NF-κB transcription factor. However, IKK-α has many additional cellular targets, and is thought to function independently of the NF-κB pathway to regulate epidermal differentiation.

Mitogen-activated protein kinase kinase kinase 7 (MAP3K7), also known as TAK1, is an enzyme that in humans is encoded by the MAP3K7 gene.

TNF receptor-associated factor 1 is a protein that in humans is encoded by the TRAF1 gene.

Interleukin-1 receptor-associated kinase 1 (IRAK-1) is an enzyme in humans encoded by the IRAK1 gene. IRAK-1 plays an important role in the regulation of the expression of inflammatory genes by immune cells, such as monocytes and macrophages, which in turn help the immune system in eliminating bacteria, viruses, and other pathogens. IRAK-1 is part of the IRAK family consisting of IRAK-1, IRAK-2, IRAK-3, and IRAK-4, and is activated by inflammatory molecules released by signaling pathways during pathogenic attack. IRAK-1 is classified as a kinase enzyme, which regulates pathways in both innate and adaptive immune systems.

TNF receptor-associated factor (TRAF3) is a protein that in humans is encoded by the TRAF3 gene.

Mitogen-activated protein kinase kinase kinase 14 also known as NF-kappa-B-inducing kinase (NIK) is an enzyme that in humans is encoded by the MAP3K14 gene.

TBK1 is an enzyme with kinase activity. Specifically, it is a serine / threonine protein kinase. It is encoded by the TBK1 gene in humans. This kinase is mainly known for its role in innate immunity antiviral response. However, TBK1 also regulates cell proliferation, apoptosis, autophagy, and anti-tumor immunity. Insufficient regulation of TBK1 activity leads to autoimmune, neurodegenerative diseases or tumorigenesis.

Mitogen-activated protein kinase kinase kinase 7-interacting protein 2 is an enzyme that in humans is encoded by the MAP3K7IP2 gene.

TRAF family member-associated NF-kappa-B activator is a protein that in humans is encoded by the TANK gene.

Transforming growth factor-β (TGF-β) principally relays its effects through the Smad pathway however, accumulating evidence indicate that alternative signalling routes are also employed by this pleiotropic cytokine. For instance recently, we [?] have demonstrated that ligand-occupied TGF-β receptors can directly trigger the TRAF6-TAK1 signalling module, resulting in MAP kinase activation. Here we report identification of the adaptor molecule TTRAP as a novel component of this non-canonical TGF-β pathway. We show that the protein associates with TGF-β receptors and components of the TRAF6-TAK1 signaling module, resulting in differential regulation of TGF-β activated p38 and NF-κB responses. Modulation of cellular TTRAP level affects cell viability in the presence of TGF-β, suggesting that the protein is an important component of the TGF-β induced apoptotic process.

Adapter protein CIKS is a protein that in humans is encoded by the TRAF3IP2 gene.

The interleukin-1 receptor (IL-1R) associated kinase (IRAK) family plays a crucial role in the protective response to pathogens introduced into the human body by inducing acute inflammation followed by additional adaptive immune responses. IRAKs are essential components of the Interleukin-1 receptor signaling pathway and some Toll-like receptor signaling pathways. Toll-like receptors (TLRs) detect microorganisms by recognizing specific pathogen-associated molecular patterns (PAMPs) and IL-1R family members respond the interleukin-1 (IL-1) family cytokines. These receptors initiate an intracellular signaling cascade through adaptor proteins, primarily, MyD88. This is followed by the activation of IRAKs. TLRs and IL-1R members have a highly conserved amino acid sequence in their cytoplasmic domain called the Toll/Interleukin-1 (TIR) domain. The elicitation of different TLRs/IL-1Rs results in similar signaling cascades due to their homologous TIR motif leading to the activation of mitogen-activated protein kinases (MAPKs) and the IκB kinase (IKK) complex, which initiates a nuclear factor-κB (NF-κB) and AP-1-dependent transcriptional response of pro-inflammatory genes. Understanding the key players and their roles in the TLR/IL-1R pathway is important because the presence of mutations causing the abnormal regulation of Toll/IL-1R signaling leading to a variety of acute inflammatory and autoimmune diseases.

Interleukin 17 receptor D is a protein that in humans is encoded by the IL17RD gene.

References

1 2 3 Wu, Ling; Zepp, Jarod; Li, Xiaoxia (2012), Lambris, John D.; Hajishengallis, George (eds.), "Function of Act1 in IL-17 Family Signaling and Autoimmunity", Current Topics in Innate Immunity II, Advances in Experimental Medicine and Biology, vol. 946, New York, NY: Springer New York, pp. 223–235, doi:10.1007/978-1-4614-0106-3_13, ISBN 978-1-4614-0105-6, PMC 6873457 , PMID 21948371
↑ "NF-κB", Wikipedia, 2022-06-21, retrieved 2022-07-06
↑ Gu, Chunfang; Wu, Ling; Li, Xiaoxia (November 2013). "IL-17 family: Cytokines, receptors and signaling". Cytokine. 64 (2): 477–485. doi:10.1016/j.cyto.2013.07.022. PMC 3867811 . PMID 24011563.
1 2 Doyle, Matthew S.; Collins, Emily S.; FitzGerald, Oliver M.; Pennington, Stephen R. (2012-10-31). "New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis". Arthritis Research & Therapy. 14 (5): 226. doi: 10.1186/ar4071 . ISSN 1478-6362. PMC 3580541 . PMID 23116200.
↑ Qian, Youcun; Zhao, Zhendong; Jiang, Zhengfan; Li, Xiaoxia (2002-07-09). "Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9386–9391. Bibcode:2002PNAS...99.9386Q. doi: 10.1073/pnas.142294499 . ISSN 0027-8424. PMC 123150 . PMID 12089335.
↑ Qian, Youcun; Zhao, Zhendong; Jiang, Zhengfan; Li, Xiaoxia (2002-07-09). "Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells". Proceedings of the National Academy of Sciences. 99 (14): 9386–9391. Bibcode:2002PNAS...99.9386Q. doi: 10.1073/pnas.142294499 . ISSN 0027-8424. PMC 123150 . PMID 12089335.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[:0-1] 1 2 3 Wu, Ling; Zepp, Jarod; Li, Xiaoxia (2012), Lambris, John D.; Hajishengallis, George (eds.), "Function of Act1 in IL-17 Family Signaling and Autoimmunity", Current Topics in Innate Immunity II, Advances in Experimental Medicine and Biology, vol. 946, New York, NY: Springer New York, pp. 223–235, doi:10.1007/978-1-4614-0106-3_13, ISBN 978-1-4614-0105-6, PMC 6873457 , PMID 21948371

[2] "NF-κB", Wikipedia, 2022-06-21, retrieved 2022-07-06

[3] Gu, Chunfang; Wu, Ling; Li, Xiaoxia (November 2013). "IL-17 family: Cytokines, receptors and signaling". Cytokine. 64 (2): 477–485. doi:10.1016/j.cyto.2013.07.022. PMC 3867811 . PMID 24011563.

[:1-4] 1 2 Doyle, Matthew S.; Collins, Emily S.; FitzGerald, Oliver M.; Pennington, Stephen R. (2012-10-31). "New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis". Arthritis Research & Therapy. 14 (5): 226. doi: 10.1186/ar4071 . ISSN 1478-6362. PMC 3580541 . PMID 23116200.

[5] Qian, Youcun; Zhao, Zhendong; Jiang, Zhengfan; Li, Xiaoxia (2002-07-09). "Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9386–9391. Bibcode:2002PNAS...99.9386Q. doi: 10.1073/pnas.142294499 . ISSN 0027-8424. PMC 123150 . PMID 12089335.

[6] Qian, Youcun; Zhao, Zhendong; Jiang, Zhengfan; Li, Xiaoxia (2002-07-09). "Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells". Proceedings of the National Academy of Sciences. 99 (14): 9386–9391. Bibcode:2002PNAS...99.9386Q. doi: 10.1073/pnas.142294499 . ISSN 0027-8424. PMC 123150 . PMID 12089335.

[1]

[2]

[3]

[4]

[6]